Abstract
The work describes QSAR and SAR studies on the TIBO derivatives as non-nucleotide reverse transcriptase inhibitor of HIV-1 using the 2D-topological, physicochemical and hydrophobic parameters, indicator parameters along with the some 3D or quantum parameters. The set of TIBO derivatives chosen for the modeling is consists of 20 compounds. Application of multiple linear regression analysis indicated that a combination of adhoc molecular descriptors and the indicator parameters yielded a statistically significant model for the prediction of activity, log1/C (50% of Effective concentration for inhibition of reverse transcriptase-1 of HIV.). The final selection of a potential TIBO derivative as non-nucleotide reverse transcriptase inhibitor of HIV-1 is made by the quantum molecular modeling.
Keywords: QSAR, anti HIV-1, Topological indices, Physicochemical properties, logP
Anti-Infective Agents in Medicinal Chemistry
Title: Chem-Bioinformatics : Computational Modeling of TIBO Derivatives
Volume: 9 Issue: 2
Author(s): Abhilash Thakur, Mamta Thakur, Neelu Agrawal and Sanjay Bhadoria
Affiliation:
Keywords: QSAR, anti HIV-1, Topological indices, Physicochemical properties, logP
Abstract: The work describes QSAR and SAR studies on the TIBO derivatives as non-nucleotide reverse transcriptase inhibitor of HIV-1 using the 2D-topological, physicochemical and hydrophobic parameters, indicator parameters along with the some 3D or quantum parameters. The set of TIBO derivatives chosen for the modeling is consists of 20 compounds. Application of multiple linear regression analysis indicated that a combination of adhoc molecular descriptors and the indicator parameters yielded a statistically significant model for the prediction of activity, log1/C (50% of Effective concentration for inhibition of reverse transcriptase-1 of HIV.). The final selection of a potential TIBO derivative as non-nucleotide reverse transcriptase inhibitor of HIV-1 is made by the quantum molecular modeling.
Export Options
About this article
Cite this article as:
Thakur Abhilash, Thakur Mamta, Agrawal Neelu and Bhadoria Sanjay, Chem-Bioinformatics : Computational Modeling of TIBO Derivatives, Anti-Infective Agents in Medicinal Chemistry 2010; 9 (2) . https://dx.doi.org/10.2174/187152110791383751
DOI https://dx.doi.org/10.2174/187152110791383751 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
In Vitro and In Vivo Sirolimus for Modulation of Allogeneic Hematopoietic Stem Cell Transplantation
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Cancer Stem Cells: How can we Target them?
Current Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers Formulation and Application of Biodegradable Nanoparticles Based Biopharmaceutical Delivery - An Efficient Delivery System
Current Pharmaceutical Design De Novo Malignancies After Organ Transplantation: Focus on Viral Infections
Current Molecular Medicine Is Innate Immunity and Inflammasomes Involved in Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Peptides Targeting Estrogen Receptor Alpha-Potential Applications for Breast Cancer Treatment
Current Pharmaceutical Design Lymphatics and Inflammation
Current Medicinal Chemistry Calcium-calpain Dependent Pathways Regulate Vesiculation in Malignant Breast Cells
Current Cancer Drug Targets Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease
Current Alzheimer Research Inhibition of Intercellular Communication between Prostate Cancer Cells by A Specific Anti-STEAP-1 Single Chain Antibody
Anti-Cancer Agents in Medicinal Chemistry Applications of Muscle Electroporation Gene Therapy
Current Gene Therapy Taming Oncogenic Signaling at Protein Interfaces: Challenges and Opportunities
Current Topics in Medicinal Chemistry Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery Recurrent Left Atrial Low-grade Malignant Inflammatory Myofibroblastic Tumor Characterized by Cardiovascular Magnetic Resonance
Current Medical Imaging Unraveling Potential Candidate Targets Associated with Expression of p16<sup>INK4a</sup> or p16 Truncated Fragment by Comparative Proteomics Analysis
Current Proteomics Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies
Anti-Cancer Agents in Medicinal Chemistry Targeting Sphingosine-1-Phosphate Receptors in Cancer
Anti-Cancer Agents in Medicinal Chemistry Proteasome Inhibitors in Cancer Therapy
Current Drug Targets Immunological Mechanism and Clinical Application of PAMP Adjuvants
Recent Patents on Anti-Cancer Drug Discovery